Get in touch
News and Press
Abata Announces Formation of Advisory Board Comprised of Leading Industry Experts in Treg Biology, Cell Therapy and Corporate Development
April 06, 2022 |
SQZ Biotechnologies Publishes Comprehensive Preclinical Research on SQZ® TAC Platform’s Ability to Induce Multiple Key Mechanisms of Antigen-Specific Tolerance and Protect Against Type 1 Diabetes
April 04, 2022 |
Jaguar Gene Therapy Announces Samsung and JDRF T1D Fund as New Investors
March 29, 2022 |
LAKE FOREST, Ill.
Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial
March 15, 2022 |
Code Biotherapeutics Announces Collaboration with Takeda to Use Proprietary 3DNA Genetic Medicine Delivery Platform to Design and Develop Gene Therapies for Rare Diseases
February 22, 2022 |
Greater Philadelphia, Pa.